|
 No pharmaceutical company, no matter what its size, has an infinite amount of money and resources to stream all its assets through its pipeline. For a portfolio, whether it is for a specific therapeutic area or an entire company, managers need to understand how their decisions to invest in one product versus another affect risk and value.
To assist with these kinds of analyses, SmartAnalyst has developed 10 Smart Questions that must be asked in order to truly understand opportunities.
Please enter your details as below to receive a free copy of this white paper.
|
